Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Remdesivir Approved by FDA Experimental Antiviral Oct/15/2020 Oct/24/2020 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Sep/14/2020 Oct/05/2020 0
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Sep/05/2020 Oct/01/2020 0
Ty1 Potential treatment - pre-clinical evidence Experimental Antiviral Sep/04/2020 Sep/08/2020 0
Simeprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/04/2020 Sep/29/2020 0
Asunaprevir Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/04/2020 Sep/08/2020 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/04/2020 Sep/26/2020 0
Grazoprevir Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/04/2020 Sep/26/2020 0